Cited by 344Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryAdvanced Drug Delivery Systems

Developments in liposomal drug delivery systems

Maurer, Norbert, Fenske, David B, Cullis, Pieter R·2001·Expert Opinion on Biological Therapy

Abstract

Liposomes are the leading drug delivery systems for the systemic (iv.) administration of drugs. There are now liposomal formulations of conventional drugs that have received clinical approval and many others in clinical trials that bring benefits of reduced toxicity and enhanced efficacy for the treatment of cancer and other life-threatening diseases. The mechanisms giving rise to the therapeutic advantages of liposomes, such as the ability of long-circulating liposomes to preferentially accumulate at disease sites including tumours, sites of infection and sites of inflammation are increasingly well understood. Further, liposome-based formulations of genetic drugs such as antisense oligonucleotides and plasmids for gene therapy that have clear potential for systemic utility are increasingly available. This paper reviews the liposomal drug delivery field, summarises the success of liposomes for the delivery of small molecules and indicates how this success is being built on to design effective carriers for genetic drugs.

Integrity signals

Registry

Crossref · 10.1517/14712598.1.6.923

Cites

194 of 194 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liposomes are generally biocompatible, biodegradable, nontoxic, and able to entrap lipophilic and hydrophilic drugs for site-specific drug delivery.

    “They are generally biocompatible, biodegradable, nontoxic, and able to entrap lipophilic and hydrophilic drugs for site-specific drug delivery.77,78”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maurer, N., Fenske, D. B., & Cullis, P. R.
Affiliations
University of British Columbia (CA)
Venue
Expert Opinion on Biological Therapy
Published
2001-11
Volume
1
Issue
6
Pages
923-947
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W2128183109
Cited by
344
References
194
Citations by year
2026: 6 · 2025: 11 · 2024: 16 · 2023: 17 · 2022: 7 · 2021: 11 · 2020: 19 · 2019: 19 · 2018: 20 · 2017: 17 · 2016: 16 · 2015: 20 · 2014: 19 · 2013: 37 · 2012: 21
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
liposomes, liposomal drug delivery, systemic drug delivery, long-circulating liposomes, tumor targeting, cancer therapy, gene therapy, antisense oligonucleotides, plasmid DNA delivery
MeSH terms
Adjuvants, Immunologic, Animals, Humans, Liposomes, Transfection, Vaccines, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review